SS
ONCY

SBI Securities’s Oncolytics Biotech ONCY Stock Holding History

SBI Securities’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13 Buy
+14
New +$13 ﹤0.01% 3903

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

SBI Securities's ONCY Position: Q2 2026 in Review

SBI Securities opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 14 shares worth $13. The stake represents ﹤0.01% of the portfolio and ranks #3903 among its holdings.

76 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • SBI Securities held 14 shares of Oncolytics Biotech worth $13 as of Q2 2026.
  • Oncolytics Biotech was a new SBI Securities position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3903 holding.
  • 76 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.